Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population

PURPOSE: This randomized, double-blind (DB), non-inferiority phase 3 study was conducted to assess the efficacy and safety of paliperidone palmitate 3-month (PP3M) vs 1-month formulation (PP1M) in European and non-European patients with schizophrenia. PATIENTS AND METHODS: In this randomized, DB, pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Savitz, Adam J, Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Ravenstijn, Paulien, Hough, David, Hargarter, Ludger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391122/
https://www.ncbi.nlm.nih.gov/pubmed/30863080
http://dx.doi.org/10.2147/NDT.S189668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391122/
https://www.ncbi.nlm.nih.gov/pubmed/30863080
http://dx.doi.org/10.2147/NDT.S189668

Ejemplares similares